T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse-Reference-Cited by-同舟云学术

T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse

Published:2015-12 Issue: Volume:99 Page:308-317
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Chou An-Hsun,Chen Ying-Ling,Chiu Ching-Chi,Yuan Shin-Je,Weng Yi-Hsin,Yeh Tu-Hsueh,Lin Yun-Lian,Fang Jim-Min,Wang Hung-Li

Funder

National Science Council of ROC

Chang Gung Medical Research Project

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference28 articles.

1. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies;Bauer;J. Neurochem.,2009

2. Positron emission tomography analysis of [11C]KW-6002 binding to human and rat adenosine A2A receptors in the brain;Brooks;Synapse,2008

3. Design and synthesis of novel dual-action compounds targeting the adenosine A2A receptor and adenosine transporter for neuroprotection;Chen;ChemMedChem,2011

4. Polyglutamine-expanded ataxin-3 activates mitochondrial apoptotic pathway by upregulating Bax and downregulating Bcl-xL;Chou;Neurobiol. Dis.,2006

5. Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation;Chou;Neurobiol. Dis.,2008

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxidative Stress in Spinocerebellar Ataxia Type 3 and Its Attenuation by Herbal Remedies in Traditional Chinese Medicine: A Systematic Review;Antioxidants;2024-03-19

2. Impact of phytomedicines and their novel delivery systems as an alternative for the treatment of neurodegenerative disorders;Phytopharmaceuticals and Herbal Drugs;2023

3. Exploring the role of protein quality control in aging and age-associated neurodegenerative diseases;Anti-Aging Drug Discovery on the Basis of Hallmarks of Aging;2022

4. Phytochemicals and their potential protective effects against spinocerebellar ataxia;Plant Extracts in Neurodegenerative Diseases;2022

5. Role of Adenosine Receptors in Rare Neurodegenerative Diseases with Motor Symptoms;Current Protein & Peptide Science;2021-09